reslizumab

CAS NO.：241473-69-8
Molecular Weight: 0
Update Date: 2026-04-24 14:59:07

What is reslizumab?

Clinical Use

Treatment of severe eosinophilic asthma

Drug interactions

Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live vaccines - avoid.

Metabolism

Reslizumab is believed to be degraded by enzymatic proteolysis into small peptides and amino acids. As reslizumab binds to a soluble target, linear non-targetmediated clearance is expected.

Properties of reslizumab

storage temp.	Store at 4°C,Do not freeze
solubility	Soluble in DMSO
form	Liquid
color	Colorless to light yellow

Safety information for reslizumab

Computed Descriptors for reslizumab

New Products

2-Ethoxyphenol Methyl 2-methoxy-5-sulfamoylbenzoate Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate 3,6-Dichloropyridazine 3,6-Dichloro-4-Isopropylpyridazine 2-[(2-Ethoxyphenoxy)methyl]oxirane m-Tolualdehyde p-Anisaldehyde 2-Bromobenzaldehyde 4-Fluorobenzaldehyde 1-Propyl-4-piperidone 3-Amino-3-(3-fluorophenyl)propanoic acid 6-Methyl-2-pyridinemethanol 2-Pyridinecarboxaldehdye tert-Butyl ((1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate 1-Indanone 2-Chloromethyl-6-methyl-pyridine 4-Morpholinoaniline Abiraterone Ethyl Ether 1-nitro-3,5-dimethyl adamantine (NMEM) Vardenafil Bis-sulphonamide(Dimer) 3-(2-aminoethyl) benzene sulfonamide Nabumetone Impurity 5 2,2-dibromo-1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one